Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.45 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.45 |
| ▸ | ERN1 | O75460 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19718104 | 0.94 | TSHR (0.42) | CA1CA2CA12CA9CA14 | |
| SCHEMBL6686810 | 0.94 | TSHR (0.50) | ALDH1A1KDM4ETSHRMAPTLMNA | |
| SCHEMBL80100 | 0.87 | TDP1 (0.42) | CA1CA2CA12CA9CA14 | |
| SCHEMBL1410169 | 0.84 | SMN1; SMN2 (0.44) | TDP1ALDH1A1KDM4ESETD7TSHR | |
| SCHEMBL18039303 | 0.83 | SETD7 (0.39) | CA1CA2CA12CA9CA14 | |
| SCHEMBL2318543 | 0.83 | MAPT (0.43) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL2342869 | 0.83 | MAPT (0.43) | ALDH1A1MAPTMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL1517330 | 0.82 | ALDH1A1 (0.38) | CA1CA2CA12CA9CA14 | |
| SCHEMBL28349555 | 0.81 | SETD7 (0.40) | ALDH1A1KDM4ESETD7TSHRMAPT | |
| SCHEMBL19718139 | 0.80 | MAPK1 (0.54) | CA1CA2ALDH1A1KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565426-B2 | Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule | JIANGNAN UNIVERSITY (CN) | 2026-03-03 | — | — | US | claimed |
| US-20220340423-A1 | Photothermal Catalytic Method for Production of Hydrogen Peroxide without Sacrificial Reagents on Basis of Porphyrin-based Supermolecule | JIANGNAN UNIVERSITY (CN) | 2022-10-27 | — | — | US | claimed |
| US-12565426-B2 | Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule | JIANGNAN UNIVERSITY (CN) | 2026-03-03 | — | — | US | disclosed |
| US-20220340423-A1 | Photothermal Catalytic Method for Production of Hydrogen Peroxide without Sacrificial Reagents on Basis of Porphyrin-based Supermolecule | JIANGNAN UNIVERSITY (CN) | 2022-10-27 | — | — | US | disclosed |
| CN-106432366-A | Preparation and application of nano metal-organic framework material PCN-223 based on porphyrin ligand | 哈尔滨理工大学 | 2017-02-22 | — | — | CN | disclosed |
| WO-2016135180-A1 | PHOTOSENSITIZER | UNIVERSITEIT VAN AMSTERDAM (NL) | 2016-09-01 | — | — | WO | disclosed |
| EP-3061762-A1 | PHOTOSENSITIZERS | Universiteit van Amsterdam (NL) | 2016-08-31 | — | — | EP | disclosed |
| WO-2015177511-A1 | METHOD OF PREPARING A METAL ORGANIC FRAMEWORK | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2015-11-26 | — | — | WO | disclosed |
| US-20040076585-A1 | Nanoparticles of cyclic tetrapyrrolic compounds as gene and drug delivery carriers | GONG XIANCHANG (US) | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565426-B2 | Photothermal catalytic method for production of hydrogen peroxide without sacrificial reagents on basis of porphyrin-based supermolecule | TPO, PPOX, THPO | CA1 1180/4885CA2 1133/4885CA12 2189/4885 |
| US-20040076585-A1 | Nanoparticles of cyclic tetrapyrrolic compounds as gene and drug delivery carriers | CCDC6, CCDC47, ABCB1 | CA1 717/4885CA2 372/4885CA12 952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.